Endacea Home Page

Description

pulled from site's meta description

Endacea is a development stage biopharmaceutical company with a proprietary A1 adenosine receptor based technology platform for the treatment of asthma, ischemia-reperfusion organ injury, and Gram-negative septicemia (endotoxemia), as well as an assay for endotoxin.


This is an automatically generated AboutUs page for ENDACEA.NET. Click the "Edit" button at the top of the page to make changes. Please read our Getting Started page if you need any help.



Retrieved from "http://aboutus.com/index.php?title=ENDACEA.NET&oldid=48128939"